Indraprastha Medical Corporation Ltd. (IMCL) is a joint venture between the Delhi Government and Apollo Hospitals, with the Delhi Government holding 22% and Apollo Hospitals owning 29%of the company. The remaining shares are distributed among institutional and retail investors. IMCL operates two major hospitals in Sarita Vihar (718 beds) and a 46-bedded facility in Noida.
IMCL specializes in tertiary and quaternary healthcare services, offering advanced medical treatments across cardiology, oncology, neurology, organ transplantation, and robotic surgery. The hospitals are equipped with state-of-the-art infrastructure, world-class medical professionals, and cutting-edge technology, making IMCL a leading healthcare provider in North India.
Indraprastha Medical Corporation Ltd. (IMCL) has announced ambitious expansion plans in its latest annual report. The company aims to add 2,000+ high-quality beds across key geographies over the next three years. This expansion aligns with IMCL’s strategy to strengthen its presence in tertiary and quaternary healthcare and meet the growing demand for advanced medical services. (Page No.3) of FY24 Annual Report. 
FY24 Annual Report
Indraprastha Medical Corporation Ltd. (IMCL) is net debt-free and holds ₹309 crore in cash as of September 2024. The company plans to utilize these funds for its expansion strategy.
Disclosure (Invested)
2 posts - 2 participants